Q1 2025 Policy Report: Tariffs, Advocacy & Action
Our latest quarterly report spotlights AdvaMed’s advocacy on tariffs—work that began the day after the election and remains front and center in our engagement with policymakers.
Inside, you’ll get a behind-the-scenes look at our strategic efforts to protect the medtech industry from harmful trade impacts—and how your voice can help us go even further.
Explore the full Q1 report and join us in shaping the future of medtech policy.